Sepsis in immunocompromised patients without human immunodeficiency virus

Randy J. McCreery, Diana F. Florescu, Andre C. Kalil

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Sepsis remains among the most common complications from infectious diseases worldwide. The morbidity and mortality rates associated with sepsis range from 20% to 50%. The advances in care for patients with an immunocompromised status have been remarkable over the last 2 decades, but sepsis continues to be a major cause of death in this population Immunocompromised patients who are recipients of a solid organ or hematopoietic stem cell transplant are living longer with a better quality of life. However, some of these patients need lifelong treatment with immunosuppressive medications to maintain their transplant status. A consequence of the need for this permanent immunosuppression is the high risk of opportunistic, community, and hospital-acquired infections, all of which can lead to sepsis. In addition, the detection of serious infections may be more challenging owing to patients' lower ability to mount the clinical symptoms that usually accompany sepsis. This article provides an update on the current knowledge of sepsis in immunocompromised patients without human immunodeficiency virus. It reviews the most pertinent causes of sepsis in this population, and addresses the specific diagnostic and therapeutic challenges in neutropenia and solid organ and hematopoietic stem cell transplantation.

Original languageEnglish (US)
Pages (from-to)S156-S165
JournalJournal of Infectious Diseases
StatePublished - 2020


  • Immunocompromised
  • Sepsis
  • Solid organ transplant
  • Stem cell transplant

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Sepsis in immunocompromised patients without human immunodeficiency virus'. Together they form a unique fingerprint.

Cite this